학술논문

Correlates of cervical mucosal antibodies to human papillomavirus 16: Results from a case control study
Document Type
Report
Author
Source
Gynecologic Oncology. Dec, 2005, Vol. 99 Issue 3, pS262
Subject
Antibodies -- Analysis
Antibodies -- Health aspects
Viral antibodies -- Analysis
Viral antibodies -- Health aspects
Papillomavirus infections -- Analysis
Papillomavirus infections -- Health aspects
Papillomaviruses -- Analysis
Papillomaviruses -- Health aspects
Language
English
ISSN
0090-8258
Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ygyno.2005.07.100 Byline: Cynthia Bierl (a), Kevin Karem (a), Alysia C. Poon (a), David Swan (a), Guillermo Tortolero-Luna (b)(c)(d), Michele Follen (b)(c), Louise Wideroff (e), Elizabeth R. Unger (a), William C. Reeves (a) Abstract: While the cervical mucosal immune response to human papillomavirus (HPV) infection is believed to be central to viral clearance, it is not well characterized. We performed this analysis to determine correlates of HPV-16-specific mucosal antibody response in women at high risk for infection with HPV. Author Affiliation: (a) Viral Exanthems and Herpesvirus Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA (b) Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA (c) Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Texas Health Science Center, Houston, TX 76107, USA (d) University of Texas, School of Public Health, Houston, TX, USA (e) Applied Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA